redbaron

Comment Stream » BSX

Comment Stream
Filter comments by:
Highest rated Latest comments
Or filter by symbol:
  • The State of Statins and Stents
    'The companies say the higher number of cancer cases is likely an anomaly.'

    I don't see how they can have it both ways, i.e., how can the drug co.'s use the data to legitimately support the use of statins, and at the same time selectively ignore the rest of the data as an 'anomaly'? And, I might add, ignore the data that shows no benefit in terms of additional longevity from the use of statins.

    One could as easily use the same data to 'selectively' conclude, 1) there is no increased longevity from these drugs, and 2) there is a 50% additional risk from cancer deaths. Again, this is selectively using the data, but isn't that what the drug companies are doing?

    How can an individual private practice doc make rational decisions for their patients, when the drug companies are self promoting the drugs in this fashion? The standard of care dictates one thing, and one could selectively interpret the data in quite the oposite fashion.

    It would seem to me that we need good statistical independent interpretation of the data, with the key word being 'independent'. And additionally, it is quite apparent to me that the drug companies are not going to be the source of that interpretation. One would also have to wonder if our FDA is independent enough to perform this task.

    As for me, I will not take the drugs again.



    Jul 27 11:54 am |Rating: 0 0 |Link to Comment |View article

redbaron's Comments Stream Stats

  • 174 Comments, 46 , 24
  • Total Comment Stream rating - = 22